A Cardington man was indicted Thursday on 41 counts in a case involving pandering sexually oriented materials involving ...

Gilead Sciences (NASDAQ: GILD) didn't have a bad first quarter, but investors didn't find it inspiring either. After ...

Shares of Gilead Sciences Inc. GILD slid 2.81% to $103.17 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to 5,525.21 and ...

Mount Gilead lost at Marion Harding on Thursday by an 11-1 score in six innings. The Indians had five hits in the contest, with Nik Coder recording a pair of singles. Hayden Pangborn was the pitcher ...

A Cardington man has been indicted on 40 counts of pandering sexually oriented materials involving minors. A Morrow County ...

Just over a month after laying off staff to focus on its lead cancer candidate, ALX Oncology announced that the asset ...

According to Benzinga Pro, Gilead Sciences's peer group average for short interest as a percentage of float is 5.92%, which ...

The company is looking to the highly anticipated launch of a closely watched HIV medicine to offset weakening demand for ...

Summer is creeping closer, and for Gilead Sciences that only means one thing: the much-anticipated launch of long-acting HIV ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Pharmaceutical stocks are making headlines today, after two U.S.-based sector heavyweights stepped into the earnings ...

The company's first-quarter revenue slipped 0.3% year-over-year to $6.67 billion, while analysts surveyed by Visible Alpha ...